Journal
ONCOTARGETS AND THERAPY
Volume 14, Issue -, Pages 1843-1855Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/OTT.S286837
Keywords
invasion; migration; cell proliferation; mTOR; Cyclin D1
Categories
Funding
- Ministry of Science and Technology [MOST 106-2314-B-016-012-MY3, MOST 108-2314-B-016-026 -MY3]
- Tri-Service General Hospital [TSGH-C107008-S05, ATSGH-C107-008-S05, TSGH-C108-007-008S05, TSGH-C01-109016, TSGH-2-C107-106-2314-B016-012-MY3, TSGH-1-C108-106-2314-B-016-012-MY3, TSGH-2-C108-106-2314-B-016-012-MY3, TSGH-2C108-108-2314-B-016-0-MY3]
- Medical Affairs Bureau, Ministry of National Defense [MAB106-019, MAB-107-009, MAB-108-022, MAB-109-014]
Ask authors/readers for more resources
The study showed higher expression of ARID4B in WHO grade IV tumors, and knocking down ARID4B suppressed glioma cell proliferation and induced apoptosis, indicating that ARID4B may act as an oncogene in human gliomas.
Purpose: Glioblastoma multiforme is a highly malignant primary brain cancer with a poor prognosis. We recently reported that ARID4B could potentially serve as a biomarker associated with poor survival in glioma patients. However, the function of ARID4B in human gliomas remains unclear. The aim of this study is to investigate the molecular cell biology role of ARID4B in human glioma cells. Materials and Methods: Gene Expression Omnibus (GEO) and Human Protein Atlas (HPA) datasets were analyzed for the expression of ARID4B in WHO pathological grading, overall survival and immunohistochemical staining. Using quantitative RT-PCR and Western blotting, those findings were confirmed in normal brain tissue and glioma cell lines. ARID4B knockdown was conducted via lentivirus-based transfection of small hairpin RNA in human glioma cells to investigate cell proliferation, cell cycle, and apoptosis. Results: In the present study, our analysis of GEO datasets showed that ARID4B mRNA expression is higher in WHO grade IV tumors (n = 81) than in non-tumor control tissue (n = 23, P <0.0001). ARID4B knockdown suppressed glioma cell proliferation and induced G1 phase arrest via the PI3K/AKT pathway. It also increased expression of HDAC1, leading to higher acetyl-p53 and acetyl-H3 levels and reduced glioma cell migration and invasion. These effects were mediated via down-regulation of AKT pathway components, including p-mTOR, p-PI3K and p-AKT. ARID4B knock-down also led to downregulation of Cyclin D1, which increased apoptosis in human glioma cells. Conclusion: These findings that ARID4B expression correlates positively with WHO pathologic grading in glioma. ARID4B knockdown suppresses PI3K/AKT signaling and induces apoptosis in human glioma cells. These results suggests that ARID4B acts as an oncogene in human gliomas.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available